150 related articles for article (PubMed ID: 33163728)
1. Hyperacute Onset of Immune Checkpoint Inhibitor-Related Acute Interstitial Nephritis.
Tawhari I; Fenton SE; Sosman JA; Sustento-Reodica N; Kanwar YS; Aggarwal V
Kidney Int Rep; 2020 Nov; 5(11):2084-2088. PubMed ID: 33163728
[No Abstract] [Full Text] [Related]
2. Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis.
Qualls D; Seethapathy H; Bates H; Tajmir S; Heidari P; Endres P; Reynolds K; Lawrence D; Sise M
J Immunother Cancer; 2019 Dec; 7(1):356. PubMed ID: 31864416
[TBL] [Abstract][Full Text] [Related]
3. Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor.
Escandon J; Peacock S; Trabolsi A; Thomas DB; Layka A; Lutzky J
J Immunother Cancer; 2017; 5():3. PubMed ID: 28105370
[TBL] [Abstract][Full Text] [Related]
4. Severe acute interstitial nephritis after combination immune-checkpoint inhibitor therapy for metastatic melanoma.
Murakami N; Borges TJ; Yamashita M; Riella LV
Clin Kidney J; 2016 Jun; 9(3):411-7. PubMed ID: 27274826
[TBL] [Abstract][Full Text] [Related]
5. Acute interstitial nephritis and PR3-ANCA following reintroduction of pembrolizumab: a case report.
Mulroy M; Ghafouri S; Sisk A; Ribas A; Goshtaseb R; Cherry G; Shen J
Immunotherapy; 2021 Mar; 13(4):283-288. PubMed ID: 33397120
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Inhibitor-Associated AKI: Debates in Diagnosis, Management, and Rechallenge.
Seethapathy H; Herrmann SM; Rashidi A
Semin Nephrol; 2022 Nov; 42(6):151346. PubMed ID: 37137187
[TBL] [Abstract][Full Text] [Related]
7. Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates.
Singh S; Clemente LC; Parra ER; Tchakarov A; Yang C; Li Y; Long JP; Yee C; Lin JS
Oncoimmunology; 2022; 11(1):2124678. PubMed ID: 36185804
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
Cortazar FB; Kibbelaar ZA; Glezerman IG; Abudayyeh A; Mamlouk O; Motwani SS; Murakami N; Herrmann SM; Manohar S; Shirali AC; Kitchlu A; Shirazian S; Assal A; Vijayan A; Renaghan AD; Ortiz-Melo DI; Rangarajan S; Malik AB; Hogan JJ; Dinh AR; Shin DS; Marrone KA; Mithani Z; Johnson DB; Hosseini A; Uprety D; Sharma S; Gupta S; Reynolds KL; Sise ME; Leaf DE
J Am Soc Nephrol; 2020 Feb; 31(2):435-446. PubMed ID: 31896554
[TBL] [Abstract][Full Text] [Related]
9. Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
Sise ME; Wang Q; Seethapathy H; Moreno D; Harden D; Smith RN; Rosales IA; Colvin RB; Chute S; Cornell LD; Herrmann SM; Fadden R; Sullivan RJ; Yang NJ; Barmettler S; Wells S; Gupta S; Villani AC; Reynolds KL; Farmer J
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657813
[TBL] [Abstract][Full Text] [Related]
10. Nephrotic syndrome with acute kidney injury due to combination therapy of immune checkpoint inhibitors: a case report and review of the literature.
Saiki R; Katayama K; Saiki H; Fukumori A; Tsujimoto K; Yamawaki M; Tanaka F; Takahashi D; Oda K; Suzuki Y; Murata T; Dohi K
BMC Nephrol; 2024 Feb; 25(1):51. PubMed ID: 38336610
[TBL] [Abstract][Full Text] [Related]
11. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.
Manohar S; Ghamrawi R; Chengappa M; Goksu BNB; Kottschade L; Finnes H; Dronca R; Leventakos K; Herrmann J; Herrmann SM
Kidney360; 2020 Jan; 1(1):16-24. PubMed ID: 35372854
[TBL] [Abstract][Full Text] [Related]
12. Short-term steroid therapy for immune-checkpoint-inhibitor-related acute kidney injury.
Tanemoto M; Iida Y; Kasai T
Int Urol Nephrol; 2024 Mar; 56(3):1199-1200. PubMed ID: 37646970
[No Abstract] [Full Text] [Related]
13. Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor-A Report of 3 Cases.
Herrmann SM; Alexander MP; Romero MF; Zand L
Kidney Med; 2020; 2(5):657-662. PubMed ID: 33089143
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Delayed-Onset Acute Interstitial Nephritis following Nivolumab Treatment in a Patient with Advanced Esophagogastric Junction Cancer].
Ozawa T; Shoda K; Kawaguchi Y; Akaike H; Maruyama S; Takiguchi K; Shiraishi K; Furuya S; Saito R; Nakata Y; Amemiya H; Kawaida H; Ashizawa N; Nakayama Y; Ichikawa D
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1633-1635. PubMed ID: 38303365
[TBL] [Abstract][Full Text] [Related]
15. Histological diagnosis of immune checkpoint inhibitor induced acute renal injury in patients with metastatic melanoma: a retrospective case series report.
Hultin S; Nahar K; Menzies AM; Long GV; Fernando SL; Atkinson V; Cebon J; Wong MG
BMC Nephrol; 2020 Sep; 21(1):391. PubMed ID: 32894101
[TBL] [Abstract][Full Text] [Related]
16. [INTERSTITIAL NEPHRITIS CAUSED BY IPILIMUMAB AND NIVOLUMAB COMBINATION THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A CASE REPORT].
Ishii M; Takezawa K; Imamura R; Fukuhara S; Fujita K; Uemura M; Kiuchi H; Nonomura N
Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):109-112. PubMed ID: 35444079
[TBL] [Abstract][Full Text] [Related]
17. The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.
Seethapathy H; Zhao S; Chute DF; Zubiri L; Oppong Y; Strohbehn I; Cortazar FB; Leaf DE; Mooradian MJ; Villani AC; Sullivan RJ; Reynolds K; Sise ME
Clin J Am Soc Nephrol; 2019 Dec; 14(12):1692-1700. PubMed ID: 31672794
[TBL] [Abstract][Full Text] [Related]
18. Acute interstitial nephritis related to immune checkpoint inhibitors.
Belliere J; Meyer N; Mazieres J; Ollier S; Boulinguez S; Delas A; Ribes D; Faguer S
Br J Cancer; 2016 Dec; 115(12):1457-1461. PubMed ID: 27832664
[TBL] [Abstract][Full Text] [Related]
19. The role of kidney biopsy in immune checkpoint inhibitor nephrotoxicity.
Moss EM; Perazella MA
Front Med (Lausanne); 2022; 9():964335. PubMed ID: 36035427
[TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
Koda R; Watanabe H; Tsuchida M; Iino N; Suzuki K; Hasegawa G; Imai N; Narita I
BMC Nephrol; 2018 Feb; 19(1):48. PubMed ID: 29486725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]